YK9-13245-82154
3 vaccinations
3 coded responses
19 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 288 / NC
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
69T-15426-29092
Child or adolescent in my care · Male · 2022-06-24
H9G-28711-20197
Child or adolescent in my care · Male · 2022-06-24
Timeline
-
2021-01-04
Registered in v-safe
-
2021-01-04
Dose 1 — Pfizer-BioNTech
- 2021-01-04
-
2021-01-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
-
2021-01-18
Survey response — day 14, dose 1MedDRA: Headache, Injection site erythema, Injection site pain, Medical counselling, Muscle spasms, Neck pain, Paraesthesia, Self-medication — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: 01/14: pain and redness at injection site; tingling fingers and neck muscle pain on same side.01/15-18: splitting headache and severe neck pain; ibuprofen/apap around the clock; MD thinks muscle spasms related to 01/14.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-25
Dose 2 — Pfizer-BioNTech
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-03
- 2021-03-08
- 2021-03-19
- 2021-04-26
-
2021-07-28
Survey response — 6 months, dose 2MedDRA: Medical counselling, Muscle spasms — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I had a second occurrence of severe neck and back spasms on my right side. I had this same effect about a week after my first vaccine and physician determined it was an inflammatory response to vaccine. Lasted about 3 weeks in July.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-28
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-03
-
2021-11-16
Dose 3 — Moderna
- 2022-01-23
-
2022-01-25
Survey response — 12 months, dose 2MedDRA: Ageusia, Anosmia, Brain fog, Cough, Exposure to SARS-CoV-2, Fatigue, Headache, Oropharyngeal pain, Quarantine — Feeling: Fair · Be unable to work or attend schoolFree text: Currently quarantining with COVID symptoms and exposure. Headache, fatigue, cough, mild sore throat, "brain fog", muted sense of taste and smell x4 days. Tested negative on rapid x4.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-17
- 2022-11-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Pfizer-BioNTech | |
| 2 | 2021-01-25 | Pfizer-BioNTech | |
| 3 | 2021-11-16 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-18 | Unsuccessful | |
| 2021-07-28 | Unsuccessful |
Free text
Release 2 — day 14, dose 1
Symptoms: 01/14: pain and redness at injection site; tingling fingers and neck muscle pain on same side.01/15-18: splitting headache and severe neck pain; ibuprofen/apap around the clock; MD thinks muscle spasms related to 01/14.
Release 9 — 6 months, dose 2
Symptoms: I had a second occurrence of severe neck and back spasms on my right side. I had this same effect about a week after my first vaccine and physician determined it was an inflammatory response to vaccine. Lasted about 3 weeks in July.
Release 11 — 12 months, dose 2
Symptoms: Currently quarantining with COVID symptoms and exposure. Headache, fatigue, cough, mild sore throat, "brain fog", muted sense of taste and smell x4 days. Tested negative on rapid x4.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Medical counselling | ✓ | ✓ | ✓ |
| SD | Muscle spasms | ✓ | ✓ | ✓ |
| SD | Neck pain | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Quarantine | · | · | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release